No Detail Found!

Cholesterol lowering effects of lovastatin and tocotrienois.

Author(s)
Dilshad Ahmed Khan Department of Pathology, Army Medical College, Rawalpindi, Pakistan
Farooq Ahmad Khan Armed Forces Institute of Pathology (AFIP), Rawalpindi, Pakistan
Aamir Ijaz Armed Forces Institute of Pathology (AFIP), Rawalpindi, Pakistan
Muhammad Dilawar Armed Forces Institute of Pathology (AFIP), Rawalpindi, Pakistan
Masood Anwar Armed Forces Institute of Pathology (AFIP), Rawalpindi, Pakistan
I Asaf Ali Quresh Advanced Medical Research, 8251 Raymond Road. 53719, Madison, WI, USA
Abstract
A double-blind clinical trial was planed to evaluate the effects of low dose of lovastatin and tocotrienols on serum cholesterol and lipoproteins in hypercholesterolemic human volunteers using American Heart Association Step-1 diet (AHA Step1 diet). The study was carried out at AFIP, Rawalpindi. Twenty-eight hypercholesterolemic subjects with serum cholesterol > 6.2 mmol/I were included in the study. They were given AHA Step-1 diet for four weeks (phase-1) and lovastatin (20 mg/day) was added for next four weeks (phase II). The subjects were then divided into two equal groups A and B. Subjects of group A were given lovastatin + tocotrienols daily and those of group B were given lovastatin + (a-tocopherol daily for four weeks (phase-III). In phase IV, subjects of the two groups were crossed-over. Lipoprotein coronary risk factors e.g. serum total cholesterol, LDL­cholesterol, HDL-cholesterol Lipoprotein(a) [Lp(a)] and triglycerides were analysed in these subjects by routine methods. Lovastatin treatment during phase II showed a drop in serum total cholesterol, LDL-cholesterol, and triglycerides by 16%, 23% and 11% in group-A respectively and 14%, 20% and 10% in group-B respectively (p
Publication Details
Page(s) 93-99
DOI DOI not available
Published Journal: Pakistan Journal of Pathology, Volume: 15, Issue: 3, Year: 2004

Request the full text from PASTIC

0

Citations

0

Downloads

45

Views